Featured Research

from universities, journals, and other organizations

Kidney dialysis machine invented for babies safely treats newborn with multiple organ failure in world first breakthrough

Date:
May 23, 2014
Source:
The Lancet
Summary:
A miniaturized kidney dialysis machine capable of treating the smallest babies has been invented, and for the first time, it has been used to safely treat a newborn baby with multiple organ failure. This technology has the potential to revolutionize the treatment of infants with acute kidney injury, according to new research published.

It is estimated that 18% of low-birthweight infants are affected by acute kidney injury and it is increasingly common in children admitted to hospital, with an incidence of almost 20% in children admitted to intensive care. (Stock image)
Credit: Iriana Shiyan / Fotolia

Italian scientists have developed a miniaturized kidney dialysis machine capable of treating the smallest babies, and have for the first time used it to safely treat a newborn baby with multiple organ failure. This technology has the potential to revolutionize the treatment of infants with acute kidney injury, according to new research published in The Lancet.

The new continuous renal replacement therapy (CRRT) machine -- named CARPEDIEM (Cardio-Renal Pediatric Dialysis Emergency Machine) -- was created to overcome the problems of existing dialysis machines that are only designed for adults and have to be adapted for use in newborns and small infants.

"Such modifications make adult devices inaccurate when used in infants smaller than 15kg and can result in complications with fluid management and treatment delivery," explains lead author Professor Claudio Ronco from San Bortolo Hospital in Vicenza, Italy. "A major problem is the potential for errors in ultrafiltration volumes -- adult dialysis equipment has a tendency to either withdraw too much fluid from a child, leading to dehydration and loss of blood pressure, or too little fluid, leading to high blood pressure and edema."

To address these technical challenges, Professor Ronco and colleagues developed a miniaturised device for kidney support in newborn babies and small infants weighing between 2kg and 10kg. It has the capacity to accurately handle very low blood and ultrafiltration flows compared with existing machines, allowing the use of a much smaller sized catheter than is typically used in children, which could prevent damage to blood vessels.

In August, 2013, at the San Bortolo Hospital in Italy, a newborn baby weighing just 2.9kg became the first person in the world to be treated with the device following multiple organ failure due to a complicated delivery. After more than 20 days of treatment with the device, doctors were able to discontinue renal support. Organ function was restored and the newborn patient was discharged from hospital after 50 days.

According to Professor Ronco, "We have shown how the technical challenges of providing CRRT can be overcome without relying on the adaptation of technology used in adult settings, and that a CRRT device designed specifically for use in neonates and small children can be used to safely and effectively treat acute kidney injury in small paediatric patients. We hope that our success will encourage the development of other medical technologies (eg, catheters, fluids, and monitors) specifically designed for infants and small children."

It is estimated that 18% of low-birthweight infants are affected by acute kidney injury and it is increasingly common in children admitted to hospital, with an incidence of almost 20% in children admitted to intensive care.

Writing in a linked Comment, Benjamin Laskin from The Children's Hospital of Philadelphia in the USA and Bethany Foster from Montreal Children's Hospital in Canada say, "The child survived the neonatal period, an outcome that would have been less likely just several years ago, without the new machine or improvements in overall neonatal care…[However] although the initial results with the new device are encouraging, more research will be needed to determine whether adequate solute clearance can be achieved in all patients with the low blood-flow rates and reduced-volume filters of CARPEDIEM."


Story Source:

The above story is based on materials provided by The Lancet. Note: Materials may be edited for content and length.


Journal Reference:

  1. Claudio Ronco, Francesco Garzotto, Alessandra Brendolan, Monica Zanella, Massimo Bellettato, Stefania Vedovato, Fabio Chiarenza, Zaccaria Ricci, Stuart L Goldstein. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). The Lancet, 2014; 383 (9931): 1807 DOI: 10.1016/S0140-6736(14)60799-6

Cite This Page:

The Lancet. "Kidney dialysis machine invented for babies safely treats newborn with multiple organ failure in world first breakthrough." ScienceDaily. ScienceDaily, 23 May 2014. <www.sciencedaily.com/releases/2014/05/140523082842.htm>.
The Lancet. (2014, May 23). Kidney dialysis machine invented for babies safely treats newborn with multiple organ failure in world first breakthrough. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/05/140523082842.htm
The Lancet. "Kidney dialysis machine invented for babies safely treats newborn with multiple organ failure in world first breakthrough." ScienceDaily. www.sciencedaily.com/releases/2014/05/140523082842.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins